-
1دورية أكاديمية
المؤلفون: Lara, Primo N, Moon, James, Redman, Mary W, Semrad, Thomas J, Kelly, Karen, Allen, Jeffrey, Gitlitz, Barbara, Mack, Philip C, Gandara, David R
المصدر: Clinical Lung Cancer. 17(2)
مصطلحات موضوعية: Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Cancer, Lung, Clinical Research, Lung Cancer, Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Small Cell, Databases, Factual, Female, Humans, L-Lactate Dehydrogenase, Lung Neoplasms, Male, Middle Aged, Neoplasm Staging, Patient Outcome Assessment, Platinum Compounds, Prognosis, Prospective Studies, Receptors, Vascular Endothelial Growth Factor, Recombinant Fusion Proteins, Survival Analysis, Therapies, Investigational, Topotecan, Treatment Outcome, Young Adult, Clinical trials, Disease control rate, Landmark analysis, Outcomes, Small-cell lung cancer, Targeted therapy, Tumor assessment, Clinical Sciences, Oncology & Carcinogenesis, Clinical sciences, Oncology and carcinogenesis
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/50n8x82cTest
-
2
المؤلفون: Thomas J. Semrad, Philip C. Mack, James Moon, Karen Kelly, Primo N. Lara, Barbara J. Gitlitz, Mary W. Redman, Jeffrey Warren Allen, David R. Gandara
المصدر: Lara, PN; Moon, J; Redman, MW; Semrad, TJ; Kelly, K; Allen, J; et al.(2016). Disease Control Rate at 8 Weeks Predicts Subsequent Survival in Platinum-Treated Extensive Stage Small-Cell Lung Cancer: Results from the Southwest Oncology Group (SWOG) Database. Clinical Lung Cancer, 17(2), 113-118. doi: 10.1016/j.cllc.2015.09.003. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/50n8x82cTest
Clinical lung cancer, vol 17, iss 2مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Tumor assessment, Lung Neoplasms, Databases, Factual, Investigational, Platinum Compounds, computer.software_genre, Targeted therapy, Clinical trials, 0302 clinical medicine, Landmark analysis, Receptors, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Medicine, Disease control rate, Prospective Studies, Carcinoma, Small Cell, Prospective cohort study, Lung, Cancer, Aged, 80 and over, Database, Vascular Endothelial Growth Factor, Therapies, Investigational, Lung Cancer, Hazard ratio, Middle Aged, Prognosis, humanities, Treatment Outcome, 030220 oncology & carcinogenesis, Population study, Female, Adult, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Recombinant Fusion Proteins, Clinical Sciences, Oncology and Carcinogenesis, Outcomes, Small-cell lung cancer, Article, Databases, Young Adult, 03 medical and health sciences, Clinical Research, Internal medicine, Humans, Oncology & Carcinogenesis, Extensive stage, Lung cancer, Factual, Survival analysis, Aged, Neoplasm Staging, L-Lactate Dehydrogenase, business.industry, Proportional hazards model, Carcinoma, Small Cell, medicine.disease, Survival Analysis, Patient Outcome Assessment, Clinical trial, Receptors, Vascular Endothelial Growth Factor, 030104 developmental biology, Therapies, Topotecan, business, computer
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b94c08f9baa1812fd92ce4d43c6fd3c0Test
https://doi.org/10.1016/j.cllc.2015.09.003Test